The Difference Between THC and CBD

Cannabis contains over 100 naturally occurring compounds called cannabinoids, with tetrahydrocannabinol (THC) and cannabidiol (CBD) being the two most well-known. While both have significant therapeutic potential, they interact with the body in different ways. Understanding these differences can help consumers and healthcare providers determine which cannabinoid or combination is best suited for specific health goals. Despite their shared origins, THC and CBD produce distinct effects. THC is primarily known for its psychoactive properties, while CBD provides therapeutic benefits without intoxication. However, research shows that using them together in varying ratios can create a balanced effect, helping individuals manage conditions that involve both psychological and physical components, such as chronic pain, Parkinson’s disease, and anxiety-related muscle tension.

What Are THC and CBD?

THC and CBD are both derived from cannabis plants but have distinct chemical structures and effects on the body.

• THC (Tetrahydrocannabinol): The primary psychoactive compound in cannabis, responsible for the "high" associated with marijuana use. It is found in higher concentrations in marijuana than in hemp.

• CBD (Cannabidiol): A non-psychoactive cannabinoid known for its potential therapeutic effects without intoxication. It is present in both hemp and marijuana but is typically extracted from hemp due to its higher CBD content.

Both cannabinoids have been studied for their health benefits, but their mechanisms of action differ significantly. Many conditions involve a mix of neurological, muscular, and inflammatory factors, making the choice between THC, CBD, or a combination an important consideration.

How They Work in the Body

THC and CBD interact with the endocannabinoid system (ECS), a network of receptors and neurotransmitters that regulate various physiological functions, including pain, mood, appetite, and immune response.

• THC primarily binds to CB1 receptors, which are abundant in the brain and central nervous system. This interaction is responsible for its psychoactive effects, such as euphoria and altered perception. THC’s effect on these receptors also contributes to its ability to relieve pain, reduce nausea, and stimulate appetite.
• CBD interacts indirectly with CB1 and CB2 receptors but does not strongly bind to them. Instead, it influences the ECS by enhancing the availability of natural endocannabinoids and interacting with other receptor systems, such as serotonin and vanilloid receptors, which regulate mood, pain, and inflammation. This broader interaction allows CBD to counteract some of THC’s psychoactive effects while providing anti-inflammatory, neuroprotective, and anxiolytic properties.

Effects and Therapeutic Uses

While both cannabinoids offer therapeutic benefits, their effects on the body are quite different. Many conditions benefit from a combined approach, as the cannabinoids complement each other.

THC: Psychoactive and Therapeutic Effects

• Euphoria and relaxation: THC activates the brain’s reward system, leading to feelings of pleasure and reduced stress.
• Pain relief: Effective in treating neuropathic pain, spinal cord injuries, arthritis, and conditions like Parkinson’s disease, which involve both nerve and muscle pain (Whiting et al., 2015).
• Muscle relaxation: Useful for muscle spasms associated with multiple sclerosis, Parkinson’s disease, and fibromyalgia.
• Appetite stimulation: Often prescribed for cancer and HIV/AIDS patients to combat weight loss (Zaller et al., 2015).
• Nausea reduction: Used in chemotherapy-induced nausea and vomiting (Parker et al., 2011).
• Sleep aid: May help with insomnia, though long-term use can impact sleep cycles.

CBD: Non-Psychoactive and Therapeutic Effects

• Anxiety and stress relief: CBD interacts with serotonin receptors to reduce symptoms of anxiety and depression (Blessing et al., 2015).
• Anti-inflammatory properties: Beneficial for conditions like arthritis, inflammatory bowel disease, and neuroinflammation, which can contribute to neurological conditions like Parkinson’s and Alzheimer’s (Burstein, 2015).
• Seizure management: FDA-approved for treating epilepsy through the drug Epidiolex (Devinsky et al., 2017).
• Neuroprotection: Investigated for potential benefits in Alzheimer’s, Parkinson’s, and multiple sclerosis, where inflammation and oxidative stress play a role in disease progression.
• Pain modulation: Can help with chronic pain, particularly when combined with THC to balance effects and reduce unwanted psychoactivity.
• Muscle support: While THC provides muscle relaxation, CBD helps reduce muscle tension and spasms without intoxication.

Choosing the Right Product: THC, CBD, or Both?

The choice between THC and CBD depends on individual health goals and tolerance levels.

• Start with CBD if you want relief from anxiety, inflammation, or chronic pain without intoxication.
• Use THC for conditions that benefit from its psychoactive and pain-relieving properties, such as chemotherapy-induced nausea or neuropathic pain.
• Consider a combination of THC and CBD (full-spectrum cannabis) for conditions like chronic pain, back pain involving both nerve and muscle inflammation, or neurodegenerative diseases. A low-THC, high-CBD ratio can provide therapeutic benefits without overwhelming psychoactive effects, making it a better option for those who want symptom relief without a strong high.

Balancing THC and CBD for Better Results

Many consumers are unaware that their condition may involve both physical and psychological factors. Chronic pain, for example, often has both a neuropathic and muscular component, requiring a more nuanced approach. A common strategy is to use a small amount of THC alongside CBD, as CBD can counteract the psychoactive effects of THC while enhancing its therapeutic benefits. This approach is useful for individuals who:

• Want pain relief but are sensitive to THC’s intoxicating effects.
• Need muscle relaxation along with nerve pain reduction.
• Are seeking symptom relief for conditions like Parkinson’s, multiple sclerosis, or fibromyalgia, where both neurological and muscular components are involved.

Dispensary vs. Non-Dispensary Products

It is crucial to choose dispensary-sourced cannabis products for the following reasons:

• Lab-tested for purity and potency: Ensures accurate labeling of CBD/THC content.
• Free from contaminants: Non-dispensary products may contain pesticides, heavy metals, or residual solvents.
• Proper dosage: Over-the-counter CBD often contains subtherapeutic "marketing doses" rather than clinically effective amounts.

Consumers should consult healthcare professionals familiar with cannabis therapy to determine the appropriate cannabinoid ratio and dosage for their needs.

Conclusion

THC and CBD are both powerful cannabinoids with distinct effects on the body. While THC is best known for its psychoactive properties and ability to alleviate pain and nausea, CBD offers a non-intoxicating alternative for anxiety, inflammation, and neurological conditions. Choosing between the two, or using them in combination, depends on individual health needs and the desired therapeutic outcome. A balanced approach using low-dose THC with CBD can help maximize benefits while minimizing unwanted psychoactive effects. Always opt for lab-tested, dispensary-grade products to ensure quality, safety, and efficacy.

---

Authorship and Transparency

This article is opinion, written and medically reviewed by Hytiva's Chief Science Officer, Robert Seik, PharmD, FMNM based on emerging medical research. It's contents may be updated periodically to reflect new research from Hytiva and others, as well as the changing perspectives of the medical community. Specific examples are examples, hypothetical, or names are changed for patient anonymity. While the contents of this article are medically reviewed, each individual is unique and readers should only make medical decisions with the advice and consultation of their doctor.

References

• Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.
• Burstein, S. (2015). Cannabidiol (CBD) and its analogs: A review of their effects on inflammation. Bioorganic & Medicinal Chemistry, 23(7), 1377-1385.
• Devinsky, O., Patel, A. D., Thiele, E. A., Wong, M. H., Appleton, R., & Harden, C. L. (2017). Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. New England Journal of Medicine, 376(21), 2011-2020.
• Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011). Regulation of nausea and vomiting by cannabinoids. British Journal of Pharmacology, 163(7), 1411-1422.
• Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364.
• Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., … & Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456-2473.
• Zaller, N. D., Yokell, M. A., Green, T. C., & Ginsburg, S. (2015). Medical marijuana and opioid analgesics: Substitutes or complements? Journal of Addictive Diseases, 34(2-3), 262-268.